Aprillia Puspitasari Tunggadewi
Institut Teknologi Kesehatan Cendekia Utama Kudus

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Distribution Flow Overview of Medicine and Medical Devices at X Purwodadi Hospital Fransisca Michelline Tuwanakotta; Yulia Pratiwi; Yanulia Handayani; Mera Putri Pratitis; Aprillia Puspitasari Tunggadewi; Wildayanti Wildayanti
International Journal Of Health Science Vol. 5 No. 2 (2025): International Journal of Health
Publisher : Lembaga Pengembangan Kinerja Dosen

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55606/ijhs.v5i2.5424

Abstract

Pharmacy services in a hospital support quality health services. Distribution is a crucial aspect of hospital pharmacy services, which aims to ensure the timely availability of pharmaceutical supplies within the unit. The purpose of this study was to determine the alignment of distribution procedures at X Hospital with the Standard Operating Procedure (SOP) and Permenkes No. 72 of 2016. This study was non-experimental with a qualitative descriptive method with a total sampling technique. The instruments used in this study were checklist sheets, interview guidelines, hospital SOP, and Permenkes No. 72 of 2016. The implementation of the study was through observation, document review, and in-depth interviews with all pharmacy employees at X Hospital. Interviews were conducted with 1 key informant, 8 informants in the pharmacy warehouse section, and 29 informants in the inpatient and outpatient services sections. Data obtained from the checklist results were processed using Microsoft Excel, and the results of the interviews were transcribed and interpreted. Based on the results of interviews and observations, it was shown that the implementation of distribution refers to the hospital SOP. The distribution system used is a centralized system and UDD (Unit Dose Dispensing) for inpatients. The results of the study also showed the percentage of conformity of the distribution process with the hospital SOP of 86.8% and conformity of distribution with Permenkes No. 72 of 2016 of 66.59%.
COST EFFECTIVENESS ANALYSIS PENGGUNAAN ANTIBIOTIK INJEKSI PADA PASIEN BRONKOPNEUMONIA DI KLINIK PRATAMA RAWAT INAP GRAHA MEDIKA PATI Yulia Pratiwi; Ahmad Izul Khilmi; Wildayanti Wildayanti; Mera Putri Pratitis; Aprillia Puspitasari Tunggadewi

Publisher :

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31596/cjp.v10i2.427

Abstract

Bronchopneumonia is an infectious lung disease affecting one or more lobes of the lung, characterized by patches of infiltrate caused by bacteria, viruses, fungi, and foreign objects. The primary treatment for bronchopneumonia is antibiotic therapy. Inappropriate antibiotic use can have adverse effects, including the emergence of bacterial resistance to antibiotics, resulting in longer patient care times and higher treatment costs. Therefore, a cost-effectiveness analysis of antibiotic injection treatment for bronchopneumonia patients is necessary. The purpose of this study was to determine the cost-effectiveness of the use of antibiotic injections in bronchopneumonia patients at the Graha Medika Pati Inpatient Clinic. This study was non-experimental or observational. The sampling technique used was a total sampling that met the inclusion and exclusion criteria. Data collection was conducted retrospectively. Data taken from medical records and patient financial information includes patient characteristics data (medical record number, age, patient name, gender, length of treatment, comorbidities), patient clinical data (diagnosis, radiology, and laboratory results), drug use data (antibiotic drug class), and total treatment cost data (laboratory, radiology, antibiotic drug costs, and treatment costs). The prevalence of bronchopneumonia patients at the Graha Media Pati Inpatient Primary Clinic in 2023 was male (52%) and female (48%). The prevalence of the most elderly and very elderly years is every 20 patients (32%), the most common comorbidities are typhoid fever, as many as 29 (47%). The ACER value of Ceftriaxone Inj. is higher, which is Rp. 30,938, compared to the ACER value of Levofloxacin Inj. of Rp. 26,012, ICER value Rp. 459,652.